Here, we investigated miRNA expression in MYC-Ig translocation-positive BL-CLs and observed 64 miRNAs that were EBV- and 1q-gains-dependent dysregulated in BL-CLs: 21 of them were known to be dysregulated in BL, 10 miRNAs were not delineated yet and the remaining 33, were described for the first time in this paper to be dysregulated in BL. The gene discussed is MYC; the disease is Burkitt lymphoma.